Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

4 Analysts Have This to Say About Atlantica Sustainable

Analysts have provided the following ratings for Atlantica Sustainable (NASDAQ:AY) within the last quarter:

Benzinga

RVL Pharmaceuticals: Q1 Earnings Insights

RVL Pharmaceuticals (NASDAQ:RVLP) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Alibaba And Other Chinese Stock Investors Remain Cautious Over China's Political Body Forum With Leading Firms

China’s top political advisory body looks to host a forum next week with some of the nation’s largest private-sector firms, including Baidu, Inc (NASDAQ:BIDU), Bloomberg reports. While the conference focused on developing China’s digital economy, investors will likely watch for a possible wind-down of its year-long crackdown on the tech sector after a…

Benzinga

Where SciPlay Stands With Analysts

Within the last quarter, SciPlay (NASDAQ:SCPL) has observed the following analyst ratings:

Benzinga

Expert Ratings for Prelude Therapeutics

Prelude Therapeutics (NASDAQ:PRLD) has observed the following analyst ratings within the last quarter:

Benzinga

Carrols Restaurant Reports Mixed Q1 Results

Carrols Restaurant Group Inc (NASDAQ:TAST) reported first-quarter FY22 sales growth of 2.4% year-on-year to $399.48 million, missing the consensus of $402.37 million. Comparable restaurant sales for Burger King restaurants increased 1.6%, and Popeyes restaurants increased 2.2%. Operating expenses rose 6.7% Y/Y to $419.3 million. The operating loss for the quarter was $(19.8) million…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Rivian Sees Price Target Halved At Wedbush: Analyst Sees Potential But It's Time To 'Stop The Excuses'

Rivian Automotive Inc (NASDAQ: RIVN) has the potential to be a major electric vehicle stalwart over the next decade but it needs to start delivering models and "stop the excuses" to reach that goal, Wedbush analyst Dan Ives said on Wednesday as he

Benzinga

Recap: Aptevo Therapeutics Q1 Earnings

Aptevo Therapeutics (NASDAQ:APVO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

MeiraGTx Hldgs: Q1 Earnings Insights

MeiraGTx Hldgs (NASDAQ:MGTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology

BridgeBio Pharma Inc (NASDAQ:BBIO) has announced an exclusive license with Bristol Myers Squibb Co (NYSE:BMY) to develop and commercialize BBP-398, a potentially best-in-class SHP2 inhibitor, in oncology. Under the agreement terms, BridgeBio will receive an upfront payment of $90 million, up to $815 million in development, regulatory and sales milestone payments, and tiered royalties in…

Benzinga

Recap: Artelo Biosciences Q2 Earnings

Artelo Biosciences (NASDAQ:ARTL) reported its Q2 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Harbor Custom Dev Q1 Earnings

Harbor Custom Dev (NASDAQ:HCDI) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Indaptus Therapeutics: Q1 Earnings Insights

Indaptus Therapeutics (NASDAQ:INDP) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Immunome: Q1 Earnings Insights

Immunome (NASDAQ:IMNM) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Entera Bio Q1 Earnings

Entera Bio (NASDAQ:ENTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

10x Genomics: Q1 Earnings Insights

10x Genomics (NASDAQ:TXG) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga

Recap: PureCycle Technologies Q1 Earnings

PureCycle Technologies (NASDAQ:PCT) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Radcom: Q1 Earnings Insights

Radcom (NASDAQ:RDCM) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Olink Holding Q1 Earnings

Olink Holding (NASDAQ:OLK) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Zealand Pharma Q1 Earnings

Zealand Pharma (NASDAQ:ZEAL) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Knightscope Bags Its First Las Vegas Casino Contract

Security technology company Knightscope, Inc. (NASDAQ:KSCP) signed its first Las Vegas casino client. Financial terms were not disclosed. KSCP noted a leading U.S.-based casino and gaming facility operator with over a dozen locations across the country had purchased its first Knightscope Autonomous Security Robot (ASR) to boost its security and surveillance program. Knightscope’s…

Benzinga

NGM Bio Initiates NGM438 Phase 1/1b trial for advanced solid tumors

NGM Biopharmaceuticals, Inc. (NGM Bio) (NASDAQ: NGM) initiated a Phase 1/1b clinical study of its drug candidate NGM438 for the treatment of patients with advanced solid tumors.

Benzinga

RADCOM Shares Gain On Q1 Beat, Guidance Boost

RADCOM Ltd (NASDAQ:RDCM) reported first-quarter FY22 revenue growth of 16% year-on-year to $10.6 million, ahead of the consensus of $10.2 million. The non-GAAP gross margin contracted 100 bps to 74% as the costs expanded 19.9% Y/Y. Non-GAAP EPS of $0.04 beat the consensus loss of $(0.04). RADCOM held $70.9 million in cash and…

Benzinga

Cathie Wood Puts In Another $29M In Coinbase, Showing Conviction In Crypto Stock Amid Sell-Off

Cathie Wood-led Ark Investment Management on Wednesday further raised its exposure in Coinbase Global Inc (NASDAQ: COIN) on the day shares of the cryptocurrency exchange crashed after it reported a first-quarter loss and a significant drop in trading volume.

1 … 565 566 567 568

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.